Please enable Javascript
The HemOnc Pulse
Meeting News
The HemOnc Pulse Live
Video Insights
In Print
Subscribe
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Lymphoma
Aggressive B-Cell Lymphoma
Hodgkin Lymphoma
Indolent B-Cell Lymphoma
Mantle Cell Lymphoma
T-Cell Lymphoma
MPN
Myelofibrosis
Polycythemia Vera
MDS
Myeloma
Transplantation & Cellular Therapy
Donna Catamero, ANP-BC, OCN, CCRC
Articles by Donna Catamero, ANP-BC, OCN, CCRC
What Are the Treatment Options for Patients With Lenalidomide-Refractory Myeloma?
Donna Catamero, ANP-BC, OCN, CCRC
Myeloma
|
May 21, 2024
Donna Catamero, ANP-BC, OCN, CCRC, discusses selinexor for myeloma, the BOSTON trial, and other recent advances in myeloma.
View More
Practical Treatment Considerations for the Use of Talquetamab in Patients with Relapsed or Refractory MM
Larysa Sanchez, MD
Myeloma
|
May 12, 2023
This editorial outlines key practical points for the use of talquetamab in relapsed or refractory MM.
Read More